Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001013762-08-000486
Filing Date
2008-03-07
Accepted
2008-03-07 17:23:37
Documents
8
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 URIGEN PHARMACEUTICALS FORM 10-K/A form10ka.htm 10-K/A 1982214
2 EXHIBIT 21.1 ex211.htm EX-21.1 4139
3 EXHIBIT 23.1 ex231.htm EX-23.1 6995
4 EXHIBIT 23.2 ex232.htm EX-23.2 6963
5 EXHIBIT 31.1 ex311.htm EX-31.1 13577
6 EXHIBIT 31.2 ex312.htm EX-31.2 13314
7 EXHIBIT 32.1 ex321.htm EX-32.1 8805
8 EXHIBIT 32.2 ex322.htm EX-32.2 8841
  Complete submission text file 0001013762-08-000486.txt   2046484
Mailing Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010
Business Address 875 MAHLER ROAD SUITE 235 BURLINGAME CA 94010 (650) 697-1900
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 000-22987 | Film No.: 08675184
SIC: 2836 Biological Products, (No Diagnostic Substances)